EGF-containing pharmaceutical composition for the treatment of b

Details EGF-containing pharmaceutical composition for the treatment of b EGF-containing pharmaceutical composition for the treatment of b

1992-12-01

1995-10-03

Warden, Jill

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

53038824, A61K 3800, C07K 200, C07K 400

Patent

active

054552265

ABSTRACT:
EGF (Epidermal Growth Factor)-containing pharmaceutical composition and method for the treatment of bronchopulmonary pathologies accompanied by lesions of the bronchial epithelium utilising EGF.

REFERENCES:
patent: 4959353 (1990-09-01), Brown
Dijke et al., Biotech. Review, vol. 7, 794-798, 1989.
Paulsen, Scand. J. Gasteroenterol., vol. 128, 20-21, 1987.
American Journal of Respiratory Cell and Molecular Biology, vol. 4, No. 2, Feb. 1991, pp. 95-101.
Laboratory Investigations, vol. 59, No. 1, Jul. 1988, pp. 25-35.
Laboratory Investigations, vol. 63, No. 4, Oct. 1990, pp. 455-466.
Laboratory Investigations, vol. 60, pp. 539-547.
Am. J. Physiol., 1988, 255, C237-C245.
Am. Rev. Respir. Dis. 1985, 132, 311-320.

Affiliated with

Also associated with

Rating

EGF-containing pharmaceutical composition for the treatment of b does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with EGF-containing pharmaceutical composition for the treatment of b, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and EGF-containing pharmaceutical composition for the treatment of b will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1077329